TG-101348 10mg 10mg | Purity Not Available
Adooq Bioscience
TG-101348 is an orally bioavailable, ATP-competitive and selective inhibitor of Janus-associated kinase 2 with potential antineoplastic activity.
More Information Supplier PageTG-101348 is an orally bioavailable, ATP-competitive and selective inhibitor of Janus-associated kinase 2 with potential antineoplastic activity.
More Information Supplier PageCCT137690 is a potent inhibitor of Aurora kinases that inhibits Aurora A and B kinases with low nanomolar IC50 values in both biochemical and cellular assays.
More Information Supplier PageCCT137690 is a potent inhibitor of Aurora kinases that inhibits Aurora A and B kinases with low nanomolar IC50 values in both biochemical and cellular assays.
More Information Supplier PagePH-797804 is a diarylpyridinone inhibitor of p38 mitogen-activated protein (MAP) kinase.
More Information Supplier PageJTC-801 is a selective antagonist for the nociceptin receptor, also known as the ORL-1 receptor.
More Information Supplier PageJTC-801 is a selective antagonist for the nociceptin receptor, also known as the ORL-1 receptor.
More Information Supplier PageAZD4547 is a potent, selective and orally active pan-FGFR inhibitor, with IC50s of 0.2, 2.5, 1.8 and 165 nM for FGFR1, 2, 3 and 4, respectively.
More Information Supplier PageAZD4547 is a potent, selective and orally active pan-FGFR inhibitor, with IC50s of 0.2, 2.5, 1.8 and 165 nM for FGFR1, 2, 3 and 4, respectively.
More Information Supplier PageAZD4547 is a potent, selective and orally active pan-FGFR inhibitor, with IC50s of 0.2, 2.5, 1.8 and 165 nM for FGFR1, 2, 3 and 4, respectively.
More Information Supplier PageAZD4547 is a potent, selective and orally active pan-FGFR inhibitor, with IC50s of 0.2, 2.5, 1.8 and 165 nM for FGFR1, 2, 3 and 4, respectively.
More Information Supplier Page